ReviewInternational journal of veterinary science and medicine2018
Brucellosis: Evolution and expected comeback.
Review in International journal of veterinary science and medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed.
- Dual-targeting oral nanoparticle mucosal vaccine against brucella infection: co-targeting M cells and dendritic cells.Journal of nanobiotechnology · 2026Article
- Age-Stratified Heterogeneity of Brucellosis Awareness and Knowledge Among Hospital-Attending Adults in an Endemic Turkish Province: A Single-Center Cross-Sectional KAP Study.Tropical medicine and infectious disease · 2026Article
- The impact of previous brucellosis treatment on the clinical course of neurobrucellosis: a multicentre retrospective study.BMC infectious diseases · 2026Article
- Two novel real-time PCR assays forMicrobiology spectrum · 2026Article
- Demyelinating Neurobrucellosis Presenting With Neuropsychiatric Manifestations.Case reports in medicine · 2026Article
- First report of aFrontiers in veterinary science · 2026Article
- Cultural and behavioral drivers of zoonotic disease transmission and persistence among diverse pastoralist communities in East Africa.One health outlook · 2025Article
- Enhanced Isolation ofMicroorganisms · 2025Article
- Brucella microti and Rodent-Borne Brucellosis: A Neglected Public Health Threat.Zoonoses and public health · 2025Review
- Epidemiological and Spatiotemporal Clustering Analysis of Human Brucellosis - China, 2019-2023.China CDC weekly · 2025Article
- Preparation and application of specific chicken yolk antibodies in detectingFrontiers in veterinary science · 2025Article
- Seroepidemiology and associated risk factors of brucellosis in small ruminants of district Khanewal, Pakistan.Journal of advanced veterinary and animal research · 2024Article
- Comparative genomics of Brucella abortus and Brucella melitensis unravels the gene sharing, virulence factors and SNP diversity among the standard, vaccine and field strains.International microbiology : the official journal of the Spanish Society for Microbiology · 2024Article
- The Reasons Behind Long-Term Endemicity of Brucellosis in Low and Middle-Income Countries: Challenges and Future Perspectives.Current microbiology · 2024Review
- Review
- Epidemiology of Brucellosis in Small Ruminants of Rural and Peri-Urban Areas of Multan, Pakistan.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024Article
- Combination ofFrontiers in microbiology · 2024Article
- Seroprevalence of brucellosis in sheep and goats from Al Jufrah district in Libya.The Pan African medical journal · 2024Article
- Seroprevalence of brucellosis among animal handlers in West Bengal, India: an occupational health study.AIMS microbiology · 2024Article
- Optimization of the first extraction protocol for metabolomic studies of Brucella abortus.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brucellosis is a serious infectious disease which causes great direct and indirect economic loses for animal holders worldwide such as the reduction of milk and meat production through abortions/culling of positive reactors, the expense of disease control/eradication and farmers compensation. Although the disease was eradicated from most of the industrial countries, it remains one of the most common zoonotic diseases in developing countries being responsible for more than 500,000 new cases yearly. Brucella is considered to be a bioterrorism organism due to its low infectious doses (10-100 bacteria), capability of persistence in the environment, rapid transmission via different routes including aerosols, and finally due to its difficult treatment by antibiotics.There are many reasons to believe that a new comeback of brucellosis may occur in near future. This expectation is supported by the recent discovery of new atypical Brucella species with new genetic properties and the recent reports of (man to man) disease transmission as will be discussed later. The development of new concepts and measurements for disease control is urgently required. In the present review, the evolution of Brucella and the different factors favoring its comeback are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.